Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Vita Coco Company, Inc.'s SEC filings document financial results, operating updates, governance matters, and public-company disclosures for its beverage brand portfolio. Form 8-K reports include quarterly and annual results, guidance updates, Regulation FD disclosures, and other material events related to the company’s coconut water and better-for-you beverage operations.
Proxy materials describe annual meeting proposals, board structure, committee assignments, executive compensation, equity awards, and stockholder voting matters. Additional 8-K filings record director appointments, board retirements, officer roles, compensation arrangements, tariff-related disclosures, and the company’s capital-market reporting obligations as a Nasdaq-listed Delaware corporation.
Vita Coco Company, Inc. director Kenneth Sadowsky reported an open-market sale of 3,900 shares of common stock at a weighted average price of $82.916 per share, executed under a pre-arranged Rule 10b5-1 trading plan. After this sale, he holds 580,296 common shares directly, plus a fully vested, currently exercisable non-qualified stock option covering 27,300 shares of common stock at an exercise price of $10.178 per share, expiring on January 2, 2030.
THE CHARLES SCHWAB CORPORATION reported proposed resale activity for Common Stock and discloses recent sales by an affiliate. The filing lists two past transactions by Kenneth Sadowsky: 3,900 shares sold on 04/15/2026 for $190,835 and 3,900 shares sold on 05/20/2026 for $302,150.
Vita Coco Company, Inc. director Ira Liran reported two open-market sales of common stock on June 12, 2026. One sale was 73,842 shares at a weighted average price of $80.322 per share, with trades ranging from $77.40 to $81.42. The other was 74,232 shares at a weighted average price of $80.292, within the same price range.
The filing notes these transactions were executed under a pre-arranged Rule 10b5-1 trading plan. After the sales, Liran’s reported holdings total 402,579 shares held indirectly through family trusts and 309,871 shares held directly, leaving him with about 712,450 shares overall.
Vita Coco Company, Inc. director Ira Liran reported selling 191,926 shares of Common Stock in open-market transactions. The shares were sold at a weighted average price of about $79.14 per share under a Rule 10b5-1 trading plan. After these trades, he holds 384,103 shares directly and 476,421 shares indirectly through the Ira Liran 2012 Family Trust and the Ira Liran Revocable Trust.
Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth reported an option-related share sale. He exercised stock options to acquire a total of 30,000 shares of common stock at an exercise price of $10.178 per share, then sold 30,000 shares at $80.00 per share in an open-market transaction.
The filing states that the stock sales were made under a pre-arranged Rule 10b5-1 trading plan. After these transactions, Burth directly holds 57,910 shares of Vita Coco common stock and retains multiple non-qualified stock option awards with various exercise prices and expiration dates.
COCO reported a proposed sale of 30,000 shares of Common Stock via a stock option exercise. The filing lists the transaction date as 06/11/2026 and shows an aggregate dollar figure of $2,400,000.00 on the same line. The notice also lists multiple sales by Jonathan Burth totaling recent dispositions in March–May 2026.
Liran Ira reported acquisition or exercise transactions in this Form 4 filing.
Vita Coco Company, Inc. director Liran Ira reported a compensation-related stock grant rather than an open-market trade. He received 1,530 restricted stock units (RSUs) of common stock at a reference price of $75.18 per share under the company's 2021 Incentive Award Plan.
The RSUs vest in full on the earlier of the day immediately before the next annual stockholders meeting after the grant date or the first anniversary of the grant date, if he remains in continuous service. After this grant, Ira holds 479,871 shares directly and 572,579 shares indirectly through the Ira Liran 2012 Family Trust.
Vita Coco Company, Inc. director Jane Cecil Morreau received an equity grant of 1,530 shares of Common Stock on June 3, 2026, reported as deferred RSUs that will vest in full before the next annual stockholders meeting or on the first anniversary of the grant date, subject to continued board service. Following this grant, she directly holds 18,709 Common shares. She also holds a fully vested, currently exercisable non-qualified stock option covering 30,500 Common shares at an exercise price of $10.178 per share, expiring on July 12, 2031.
Vita Coco Company, Inc. director Kenneth Sadowsky reported a routine equity compensation grant. He received 1,530 shares of Common Stock as deferred restricted stock units (RSUs) that vest in full on the earlier of the day before the next Annual Stockholders Meeting after the grant date or the first anniversary of the grant date, as long as he remains in continuous service. These deferred RSUs will settle on June 3, 2031, with each unit delivering one share of common stock. After this grant, Sadowsky directly holds 584,196 shares of Common Stock. He also holds a fully vested, currently exercisable non-qualified stock option covering 27,300 shares of Common Stock at an exercise price of $10.178 per share, expiring on January 2, 2030.